Skip to main content
Back to HSG

HSG's Biotechnology Portfolio

Browse 63 Biotechnology companies funded by HSG. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
63
Total Funding in Biotechnology
$4.1B

Biotechnology Portfolio Companies (63)

Export
Biotechnology

Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.

Bedford, United States
June 2022
$160.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

NuProbe is a cutting-edge genomics and molecular diagnostics company.

Boston, United States
June 2022
$50.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyPrecision Medicine

RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.

Cambridge, United States
April 2025
$1.4M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

South San Francisco, United States
April 2025
$8.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company

Singapore, Singapore
March 2026
$40.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

Admiralty, Hong Kong
March 2026
$27.7M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Cambridge, United States
March 2025
$123.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Princeton, United States
February 2026
$85.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.

China, Japan
February 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

New Haven, United States
January 2025
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

Weston, United States
July 2024
$45.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

Houston, United States
December 2023
$14.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

San Diego, United States
May 2023
$35.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalMedical Device

Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.

Menlo Park, United States
January 2026
$67.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

South San Francisco, United States
December 2025
$747.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

New Haven, United States
January 2022
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyNeuroscience

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

Rockville, United States
December 2025
$53.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases

San Diego, United States
January 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Generation Lab measures molecular disbalance a marker of aging using a straightforward cheek-swab test combined with patented methodologies.

San Francisco, United States
October 2025
$11.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Menlo Park, United States
October 2025
$325.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceutical

HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.

Suzhou, China
December 2025
$17.1M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Hangzhou, China
August 2025
$55.7M
Series D

Founder Contacts

30,000+ verified contacts

Biotechnology

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Shanghai, China
July 2025
$19.5M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Suzhou, China
July 2025
$59.7M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

Suzhou, China
July 2025
$25.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Dizal Pharma is a biotechnology company that conducts research for the treatment of cancer and immunological diseases.

Shanghai, China
April 2025
$246.2M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Biomass EnergyBiotechnologyChemical

Evolyzer is a synthetic biology technology start-up that specializes in the biomanufacturing of chemicals, agriculture, and medicine.

Beijing, China
March 2025
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedical

Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.

Shanghai, China
November 2024
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedical

MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.

Haidian, China
September 2024
$14.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGenetics

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Shanghai, China
August 2024
$13.9M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Guangzhou, China
July 2024
$41.3M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Cataya Bio is a synthetic biology startup specializing in the biomanufacturing of chemical and biochemical products.

Shanghai, China
April 2024
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth Care

Atom Bioscience is a clinical-stage biotechnology company.

Suzhou, China
October 2023
$82.1M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsHealth CareMedicalMedical Device

Qihan Biotech is a gene-editing organ transplantation technology developer.

Hangzhou, China
September 2023
$16.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Neurophth is China's first gene therapy company for ophthalmic diseases.

Wuhan, China
August 2023
$97.1M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.

Guangzhou, China
June 2023
$14.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Beijing, China
May 2023
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyChemicalManufacturingMedical

Bioforany is a biocatalyst manufacturer specializing in biocatalysts development and sales.

Changsha, China
May 2023
Seed

Founder Contacts

30,000+ verified contacts

Alternative MedicineBiotechnologyMedical

HealiRNA is a ribonucleic acid drug research and development company.

Suzhou, China
March 2023
$14.5M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Suzhou WuXi Bo Rui Biotechnology is a radioactive molecular imaging and nuclear drug transformation platform.

Changping, China
September 2022
$42.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyProduct Research

Demeter Biotechnology specializes in microalgae synthetic biotechnology and provides microalgae-based products.

Zhuhai, China
August 2022
$14.5M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth CareMachine Learning

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

Cambridge, United States
April 2022
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical Device

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Changping, China
April 2022
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedicalPharmaceutical

Grit Science is a gene therapeutics firm.

Beijing, China
March 2022
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiometricsBiopharmaBiotechnology

ABclonal is a biotechnology company that is a supplier of global antibody and molecular enzyme reagents.

Wuhan, China
December 2021
$189.1M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnology

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

Huangpu, China
November 2021
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalProduct Research

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

Hangzhou, China
July 2021
$15.5M
Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareProduct Research

NeoX Biotech is a pharmaceutical company engaged in early-stage drug developmentbased on AI and computational biophysical technology.

Beijing, China
July 2021
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth Care

EdiGene is a biotechnology company that develops genome editing technologies.

Beijing, China
April 2021
$61.6M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareInnovation ManagementPharmaceutical

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

Beijing, China
March 2021
$155.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGenetics

CorrectSequence Therapeutics is a clinical-stage biotech company for next-generation gene editing therapies.

Shanghai, China
January 2021
$6.2M
Angel

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CarePharmaceutical

Yaoyanshe is a CRO technology platform that focuses on providing innovative clinical research services for the medical industry.

Shanghai, China
August 2020
$86.2M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

Shanghai, China
June 2020
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Hsinchu, Taiwan
October 2018
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsMedical

MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.

Suzhou, China
May 2018
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

Menlo Park, United States
May 2018
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio